News
Scientists have found inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment.
A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics ...
Bengaluru: Doctors in the city are witnessing a seasonal surge in respiratory infections, with influenza strains and human ...
Scientists uncover hidden inflammatory pathways behind treatment-resistant asthma attacks in kids, offering hope for more ...
Study reveals multiple inflammatory pathways driving asthma exacerbations in children, even with standard treatment. Research ...
A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that ...
Common respiratory infections like the flu and COVID-19 might jolt dormant cancer cells back to life in survivors, causing ...
Bird flu is a concern in India. The government confirmed 41 outbreaks across 10 states in 2025. Maharashtra, Chhattisgarh, ...
Acute necrotizing encephalopathy is a severe neurologic condition that can result in brain damage and swelling following a ...
Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped royalty purchase agreement with Sobi under which Apel ...
As of June 30, 2025, Apellis had $370.0 million in cash and cash equivalents, compared to $411.3 million in cash and cash equivalents as of December 31, 2024. Apellis anticipates its cash, combined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results